The Irish Cancer Societies Women’s Health Initiative was initially a two year funded project, which has been extended by a further two years ending in October 2024. The Mater Misericordiae University Hospital, with the help of Public and Patient Involvement, has called the group the “The Living Well Cancer Programme” and is supported by the Health Service Executive (HSE), The Mater Private Network, The National Cancer Control Programme (NCCP), Breakthrough Cancer Research, Pfizer Ireland, GSK, Ovacare and Patient Donations.
The WHI will focus on women impacted by breast and gynaecological cancer over the duration of the grant.
The team is led by Professor of Gynaecological Oncology at University College Dublin, Donal Brennan. The team also comprises two Clinical Nurse Specialists; (CNSs) Aidin Roberts and Louise Comerford (2020-2022), Clinical Research Fellow 2020-2022, Dr. Fionán Donohoe and 2022-2024 Dr Teresa Tracy and Research Coordinator, Yvonne O’Meara.